MedTrace Logo

Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML

NCT05309018 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-05-23

No results posted yet for this study

Summary

Advanced Practice Nurse (APN) is a new contributor in the French healthcare system. APN is part of a multidisciplinary team and aim to monitor patients under the coordination of the doctor particularly in onco-hematology. The aim of the study is to describe the different perceptions and expectations of APN monitoring according to patients with acute myeloid leukemia (AML) and their care team.

This study will involve 10 patients, recruited over a provisional period of 5 months and 25 member of care team. Patients and their care team will be asked about their perceptions and expectations of APN participation in (AML monitoring) during a semi-structured interviews.

Conditions

  • Myeloid Leukemia

Interventions

OTHER

Interviews

Semi-structured interview about perceptions and expectations of APN participation in AML monitoring according to patient and to care team.

Sponsors & Collaborators

  • Centre Hospitalier Régional Metz-Thionville

    lead OTHER

Principal Investigators

  • Jennifer HUET · CHR Metz Thionville Hopital de Mercy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2024-08-15
Completion
2024-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309018 on ClinicalTrials.gov